The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunogenomic features of pathologic response to neoadjuvant immune checkpoint blockade in esophageal cancer.
 
Zineb Belcaid
No Relationships to Disclose
 
Archana Balan
No Relationships to Disclose
 
Christopher Cherry
Research Funding - Bristol-Myers Squibb; Unity Biotechnology
 
Mara Lanis
No Relationships to Disclose
 
Kristen Marrone
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca; Compugen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Benjamin Philip Levy
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Turning Point Therapeutics (Inst)
 
Heather Schneider
No Relationships to Disclose
 
Hanika Rodavia
No Relationships to Disclose
 
Blair A Jobe
No Relationships to Disclose
 
Elizabeth Thompson
No Relationships to Disclose
 
Victor E. Velculescu
Leadership - Delfi Diagnostics; Personal Genome Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics; Personal Genome Diagnostics
Honoraria - Bristol-Myers Squibb; Genentech; Merck; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Delfi Diagnostics; Genentech; Merck; Personal Genome Diagnostics; Takeda
Research Funding - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Delfi Diagnostics; Personal Genome Diagnostics; Qiagen; Sysmex; Ventana Medical Systems
 
Richard James Battafarano
No Relationships to Disclose
 
Stephen Yang
No Relationships to Disclose
 
Stephen Broderick
No Relationships to Disclose
 
Jinny Suk Ha
No Relationships to Disclose
 
Ali H Zaidi
Stock and Other Ownership Interests - BioCryst; Bluebird Bio; Clovis Oncology; G1 Therapeutics; Iterum; Kala Pharmaceuticals; Regulus Therapeutics
 
Ronan Joseph Kelly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Lilly; Medscape; Merck; Novartis; Onc Live; Peerview; Pieris Pharmaceuticals; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca; bristol myers; Genentech; Lilly; Lilly; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Bristol Myers (Inst); genentech; Merck
 
Valsamo Anagnostou
Research Funding - Bristol-Myers Squibb; Personal Genome Diagnostics
 
Vincent K. Lam
Consulting or Advisory Role - Bristol-Myers Squibb; Seagen; Takeda
Research Funding - BMS (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Takeda (Inst)